BarentsKrans welcomes Gijs ter Braak as partner and civil-law notary in its Amsterdam office. His arrival further strengthens the firm’s corporate notarial practice and expands its capabilities in Corporate / M&A, private equity, corporate governance and corporate law.

PSD3 will replace the current distinction between payment and e-money institutions and introduce a new authorisation framework. Existing firms benefit from a transitional regime, but must demonstrate compliance with PSD3 requirements, including DORA obligations.

The Hague Court of Appeal revoked Bayer’s Dutch rivaroxaban dosage patent (EP 961) for lack of inventive step. The judgment overturns the 2023 first instance decision, dismisses Bayer’s infringement claims against Sandoz and aligns the Netherlands with several foreign courts.

BarentsKrans is pleased to announce that Joost Fanoy has been recognised in the Lexology Index Thought Leaders Netherlands 2026 guide for Competition.